EDESA BIOTECH, INC. Earnings Per Share, Basic and Diluted
EDESA BIOTECH, INC. (EDSA) reported Earnings Per Share, Basic and Diluted of -$0.33 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-02-14
- EDESA BIOTECH, INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.33.
- EDESA BIOTECH, INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.28.
- EDESA BIOTECH, INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.36.
- EDESA BIOTECH, INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.19.
- EDESA BIOTECH, INC. earnings per share, basic and diluted for fiscal 2021 was -$1.10.
- EDESA BIOTECH, INC. earnings per share, basic and diluted for fiscal 2020 was -$0.74.
- EDESA BIOTECH, INC. earnings per share, basic and diluted for fiscal 2018 was -$0.47.
- EDESA BIOTECH, INC. earnings per share, basic and diluted for fiscal 2018 was -$1.76.
| Period end | Earnings Per Share, Basic and Diluted 1 month | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | -$0.33 10-Q · filed 2022-02-14 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$0.96 derived: net income ÷ weighted average shares · filed 2023-02-10 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-02-10 | |||||
| 2021-09-30 | -$0.28 derived: net income ÷ weighted average shares · filed 2022-12-16 | -$0.64 derived: net income ÷ weighted average shares · filed 2022-12-16 | -$0.84 derived: net income ÷ weighted average shares · filed 2022-12-16 | -$1.10 10-K · filed 2021-12-28 | |||||
| 2021-06-30 | -$0.36 10-Q · filed 2021-08-13 | -$0.56 derived: net income ÷ weighted average shares · filed 2022-08-12 | -$0.83 10-Q · filed 2021-08-13 | -$1.05 derived: net income ÷ weighted average shares · filed 2022-08-12 | |||||
| 2021-03-31 | -$0.19 10-Q · filed 2021-05-14 | -$0.45 10-Q · filed 2021-05-14 | -$0.66 derived: net income ÷ weighted average shares · filed 2022-05-13 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-05-13 | |||||
| 2020-12-31 | -$0.26 10-Q · filed 2022-02-14 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-02-14 | -$0.68 derived: net income ÷ weighted average shares · filed 2022-02-14 | -$0.85 derived: net income ÷ weighted average shares · filed 2022-02-14 | |||||
| 2020-09-30 | -$0.22 derived: net income ÷ weighted average shares · filed 2021-12-28 | -$0.42 derived: net income ÷ weighted average shares · filed 2021-12-28 | -$0.59 derived: net income ÷ weighted average shares · filed 2021-12-28 | -$0.74 10-K · filed 2021-12-28 | |||||
| 2020-06-30 | -$0.20 10-Q · filed 2021-08-13 | -$0.37 derived: net income ÷ weighted average shares · filed 2021-08-13 | -$0.52 10-Q · filed 2021-08-13 | -$0.65 derived: net income ÷ weighted average shares · filed 2021-08-13 | |||||
| 2020-03-31 | -$0.17 10-Q · filed 2021-05-14 | -$0.32 10-Q · filed 2021-05-14 | -$0.45 derived: net income ÷ weighted average shares · filed 2021-05-14 | -$0.69 derived: net income ÷ weighted average shares · filed 2021-05-14 | |||||
| 2019-12-31 | -$0.15 10-Q · filed 2021-02-16 | -$0.27 derived: net income ÷ weighted average shares · filed 2021-02-16 | -$0.52 derived: net income ÷ weighted average shares · filed 2021-02-16 | -$0.68 derived: net income ÷ weighted average shares · filed 2021-02-16 | |||||
| 2019-09-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2020-12-07 | -$0.38 derived: net income ÷ weighted average shares · filed 2020-12-07 | -$0.55 10-K · filed 2020-12-07 | -$0.69 derived: net income ÷ weighted average shares · filed 2020-12-07 | |||||
| 2019-06-30 | -$0.30 10-Q · filed 2020-08-12 | -$0.48 10-Q · filed 2019-08-14 | -$0.61 10-Q · filed 2020-08-12 | -$0.72 derived: net income ÷ weighted average shares · filed 2020-08-12 | |||||
| 2019-03-31 | -$0.16 10-Q · filed 2020-05-15 | -$0.31 10-Q · filed 2019-05-08 | -$0.28 10-Q · filed 2020-05-15 | -$0.57 10-Q · filed 2019-05-08 | -$0.38 derived: net income ÷ weighted average shares · filed 2020-05-15 | -$0.51 derived: net income ÷ weighted average shares · filed 2020-05-15 | |||
| 2018-12-31 | -$0.11 10-Q · filed 2020-02-13 | -$0.26 10-Q · filed 2019-02-05 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.35 derived: net income ÷ weighted average shares · filed 2020-02-13 | -$0.47 10-KT · filed 2019-12-12 | ||||
| 2018-09-30 | -$0.11 derived: net income ÷ weighted average shares · filed 2019-12-12 | -$0.23 derived: net income ÷ weighted average shares · filed 2019-12-12 | -$0.36 10-KT · filed 2019-12-12 | -$1.76 10-K · filed 2018-11-30 | |||||
| 2018-06-30 | -$0.13 10-Q · filed 2019-08-14 | -$0.38 10-Q · filed 2018-08-08 | -$0.26 10-Q · filed 2019-08-14 | -$1.93 10-Q · filed 2018-08-08 | -$2.26 derived: net income ÷ weighted average shares · filed 2019-08-14 | ||||
| 2018-03-31 | -$0.90 10-Q · filed 2019-05-08 | -$1.83 10-Q · filed 2019-05-08 | -$2.64 derived: net income ÷ weighted average shares · filed 2019-05-08 | -$3.49 derived: net income ÷ weighted average shares · filed 2019-05-08 | |||||
| 2017-12-31 | -$0.93 10-Q · filed 2019-02-05 | -$0.13 10-Q · filed 2018-02-07 | -$1.74 derived: net income ÷ weighted average shares · filed 2019-02-05 | -$2.59 derived: net income ÷ weighted average shares · filed 2019-02-05 | -$3.35 derived: net income ÷ weighted average shares · filed 2019-02-05 | ||||
| 2017-09-30 | -$0.81 derived: net income ÷ weighted average shares · filed 2018-11-30 | -$1.65 derived: net income ÷ weighted average shares · filed 2018-11-30 | -$2.42 derived: net income ÷ weighted average shares · filed 2018-11-30 | -$3.44 10-K · filed 2018-11-30 | -$0.49 10-K · filed 2017-12-01 | ||||
| 2017-06-30 | -$0.84 10-Q · filed 2018-08-08 | -$0.12 10-Q · filed 2017-08-09 | -$1.60 derived: net income ÷ weighted average shares · filed 2018-08-08 | -$2.63 10-Q · filed 2018-08-08 | -$0.38 10-Q · filed 2017-08-09 | -$0.89 derived: net income ÷ weighted average shares · filed 2018-08-08 | |||
| 2017-03-31 | -$0.76 10-Q · filed 2018-05-07 | -$0.11 10-Q · filed 2017-05-09 | -$1.79 10-Q · filed 2018-05-07 | -$0.26 10-Q · filed 2017-05-09 | -$0.55 derived: net income ÷ weighted average shares · filed 2018-05-07 | -$0.68 derived: net income ÷ weighted average shares · filed 2018-05-07 | |||
| 2016-12-31 | -$0.15 10-Q · filed 2018-02-07 | -$0.28 derived: net income ÷ weighted average shares · filed 2018-02-07 | -$0.42 derived: net income ÷ weighted average shares · filed 2018-02-07 | -$0.53 derived: net income ÷ weighted average shares · filed 2018-02-07 | |||||
| 2016-09-30 | -$0.13 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.27 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.38 derived: net income ÷ weighted average shares · filed 2017-12-01 | -$0.57 10-K · filed 2017-12-01 | |||||
| 2016-06-30 | -$0.14 10-Q · filed 2017-08-09 | -$0.24 derived: net income ÷ weighted average shares · filed 2017-08-09 | -$0.44 10-Q · filed 2017-08-09 | ||||||
| 2016-03-31 | -$0.10 10-Q · filed 2017-05-09 | -$0.30 10-Q · filed 2017-05-09 | |||||||
| 2015-12-31 | -$0.19 10-Q · filed 2017-02-06 | ||||||||
| 2015-09-30 | -$0.36 10-K · filed 2017-12-01 | ||||||||
| 2015-03-31 | -$0.05 10-Q · filed 2016-05-09 | -$0.22 10-Q · filed 2016-05-09 | |||||||
| 2014-12-31 | -$0.17 10-Q · filed 2016-02-08 | ||||||||
| 2014-08-31 | -$0.11 10-K · filed 2014-11-21 | ||||||||
| 2013-09-30 | $0.00 10-Q · filed 2015-02-09 | ||||||||
| 2013-08-31 | -$0.28 10-K · filed 2014-11-21 | ||||||||
| 2012-08-31 | -$0.13 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |